Stephan Lapointe, DPM
Podiatrist · Rome, GANPI 1013006618
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (48.4%), consulting fees and education — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by Stryker at 57.9% of the total. Reporting peaked in 2022 at $2,511 and has fallen 98.7% since, to $32 in 2023.
Across 28 payments — averaging $216.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$4K
- Medical Device Business Services, Inc.$1K
- United Orthopedics LLC$1K
- Organogenesis Inc.$23
- Polymedics Innovations Inc.$8
What the payments were for
- Consulting fees$1,32022%
- Travel & lodging$2,93648%
- Food & beverage$61110%
- Education$1,20020%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 24 | $3,515 |
| Medical Device Business Services, Inc. | 1 | $1,320 |
| United Orthopedics LLC | 1 | $1,200 |
| Organogenesis Inc. | 1 | $23 |
| Polymedics Innovations Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PRIME SERIES$2,000
- HEALIX$1,320
- ViviGen$1,320
- VA-LCP PLATES & SCREWS$1,320
- INBONE$831
- SALVATION$260
How this compares
$6,067 in reported general payments places this provider in the 75th percentile of 177 podiatrist providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 312 | $4,971 |
| Ciclopirox | 122 | $3,274 |
| Mupirocin | 293 | $2,382 |
| Celecoxib | 164 | $2,297 |
| Colchicine | 33 | $1,110 |
| Terbinafine Hcl | 65 | $1,078 |
| Febuxostat | 18 | $1,053 |
| Duloxetine Hcl | 36 | $529 |
| Allopurinol | 77 | $498 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 70 | $473 |
| Pregabalin | 36 | $432 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 25 | $384 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 74 | $361 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 24 | $283 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 17 | $236 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Rome
- Allen RaphaelSmyrna$324K
- Ira KrausFort Oglethorpe$223K
- Stephen BarrettMarietta$82K
- Mohammad SharifAtlanta$79K
- Craig CamastaAtlanta$49K
- Ryan FitzgeraldCanton$43K
- Margo JimenezAtlanta$19K
- Samantha MinerSmyrna$17K
- Robson SpinolaJesup$15K
- Christopher CorwinJohns Creek$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.